15 patents currently held
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Sep 2027. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
2
Ending by 2030
Sep 2027
Next term end
5
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Oct 2034 · High confidence
Also notable
Ends Jan 2033 · High confidence
Also notable
Ends Oct 2035 · High confidence
Vial Adapter for a Needle-Free Syringe
US 9,345,642
The most cited patent in this portfolio, cited by 133 later US patents, top 5% of utility patents granted in 2016 in our data. Protection runs to 2034.
Needle-Free Injection Device
US 9,408,972
The largest patent family in this portfolio, 11 related applications, renewed at every maintenance window due so far. Protection runs to 2033.
Needle Free Syringe and Pre-Filling System
US 10,065,753
Granted 2018 and renewed at every maintenance window due so far. Protection runs to 2035.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 18, 2026The maintenance fee for Needle-Free Intradermal Injection Device (US 10,322,238) comes due Dec 18, 2026. Unpaid by Jun 21, 2027, it lapses early.
- 1 fee due May 5, 2027The maintenance fee for Needle-Free Injection Methods (US 10,463,795) comes due May 5, 2027. Unpaid by Nov 5, 2027, it lapses early.
Recent changes
- 2 of the patents on this record were granted since Aug 16, 2026
- 1 term has ended since Aug 16, 2026
What they patent
The 2 largest of its 5 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Needle-Free Injection Device | 10 in force | to Nov 2044 |
| Needle Free Syringe and Pre-Filling System | 2 in force | to Nov 2035 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US D690,416 | Needle-Free Syringe In force · High confidence | In force | High confidence | |
| US D695,892 | Needle-Free Syringe In force · High confidence | In force | High confidence | |
| US 10,463,795 | Needle-Free Injection Methods In force · High confidence | In force | High confidence | |
| US 9,700,675 | Needle-Free Intradermal Injection Device In force · High confidence | In force | High confidence | |
| US 9,408,972 | Needle-Free Injection Device In force · High confidence | In force | High confidence | |
| US 11,471,603 | Needle-Free Injector In force · High confidence | In force | High confidence | |
| US 10,322,238 | Needle-Free Intradermal Injection Device In force · Medium confidence | In force | Medium confidence | |
| US 12,766,264 | Needle-Free Intradermal Injection Device In force · Medium confidence | In force | Medium confidence | |
| US 11,154,659 | Needle-Free Intradermal Injection Device In force · Medium confidence | In force | Medium confidence | |
| US 12,708,711 | Needle-Free Injector In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 15: 7 patents ended · 1 application pending · 5 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.